<DOC>
	<DOCNO>NCT01911988</DOCNO>
	<brief_summary>The purpose study determine association Peripheral Immune Cells ( PIC ) recurrence stage II/III colorectal cancer</brief_summary>
	<brief_title>Study Association Between Peripheral Immune Cells Recurrence Stage II/III Colorectal Cancer</brief_title>
	<detailed_description>The investigator hypothesize differentiation Peripheral Immune Cells ( PIC ) would result resistance chemotherapy tumor local metastatic recurrence . The primary endpoint study Disease Free Survival secondary endpoint 5-year Overall Survival . 5ml peripheral blood sort counted flow cytometry point primary treatment ( surgery colon cancer , neoadjuvant therapy rectal cancer ) , first chemotherapy postoperatively 1 month last chemotherapy . Patients follow 3 monthly assessment first two year 6 monthly assessment rest three year . Stratification factor include age , BMI , gender , tumor location , rectal colon cancer stage , chemotherapy ( FOLFOX , XELOX , DeGramont Capecitabine ) , laparoscopic laprotomy , anastomosis , concomitant medication complication .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Clinically /Pahohistologically diagnose stageII/III CRC ECOG 02 Age 1890 Gender Distant metastases noticed surgery History malignant tumor disease History autoimmune diseases immunodeficiency History hematological disease History hepatic cirrhosis Splenomegaly History chronic kidney disease History organ transplant History chronic inflammatory disease Use hematological drug within 1 year prior surgery Use immunodulatory drug within 1 year prior surgery Use chemotherapeutic drug within 1 year prior surgery Long term Use nonsteroid antiinflammatory drug ( &gt; 6 month ) Unable Unwilling undergo standard treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Peripheral immune cell</keyword>
	<keyword>Colorectal Cancers</keyword>
	<keyword>Stage II/ Stage III</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Metastasis</keyword>
</DOC>